Literature DB >> 6261159

3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

P C Waldmeier, J Lauber, W Blum, W J Richter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6261159     DOI： 10.1007/bf00499838

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  28 in total

1.  A mass fragmentographic assay of 3-methoxytyramine in rat brain.

Authors:  C L Galli; F Cattabeni; T Eros; P F Spano; S Algeri; A Di Giulio; A Groppetti
Journal:  J Neurochem       Date:  1976-09       Impact factor: 5.372

2.  On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.

Authors:  P C Waldmeier; L Maître
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

3.  Substrate and inhibitor selectivity of human heart monoamine oxidase.

Authors:  D Parkinson; B A Callingham
Journal:  Biochem Pharmacol       Date:  1979-05-15       Impact factor: 5.858

4.  3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.

Authors:  A Groppetti; M Parenti; C L Galli; A Bugatti; F Cattabeni; A M Di Giulio; G Racagni
Journal:  Life Sci       Date:  1978-10-30       Impact factor: 5.037

5.  Postmortal accumulation of 3-methoxytyramine in brain.

Authors:  A Carlsson; M Lindqvist; W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.

Authors:  J A Roth; K Feor
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

7.  Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.

Authors:  C Braestrup
Journal:  J Pharm Pharmacol       Date:  1977-08       Impact factor: 3.765

8.  Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

9.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

Review 10.  Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.

Authors:  W Kehr; W Speckenbach; R Zimmermann
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575
View more
  7 in total

Review 1.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Analysis of cat retina for dopamine, dihydroxyphenylacetic acid, 3-methoxytyramine and homovanillic acid.

Authors:  D M Vaughn; D M Lindley; N R Cox; S T Simpson; W L Whitmer
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

3.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.

Authors:  F Karoum; M F Egan
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism.

Authors:  E Panula-Lehto; M Mäkinen; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

5.  Interactions of morphine with apomorphine: behavioural and biochemical studies.

Authors:  H G Möller; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

6.  Cytotoxic, genotoxic, and neurotoxic effects of Mg, Pb, and Fe on pheochromocytoma (PC-12) cells.

Authors:  Talia Sanders; Yi-Ming Liu; Paul B Tchounwou
Journal:  Environ Toxicol       Date:  2014-06-18       Impact factor: 4.119

7.  3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Authors:  C F Saller; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.